A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects

ObjectiveThis study was conducted to explore the tolerance, variability, pharmacokinetics (PK), and pharmacodynamics (PD) of denosumab biosimilar (QL1206) in healthy Chinese subjects.MethodsThis is a randomized, double-blind, two-arm, parallel study performed to examine the bioequivalence of denosum...

全面介紹

書目詳細資料

Principais autores:	Hong Zhang, Min Wu, Xiaoxue Zhu, Cuiyun Li, Xiaojiao Li, Jixuan Sun, Chengjiao Liu, Quan Liu, Wei Wei, Junqi Niu, Yanhua Ding
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2020-10-01
叢編:	Frontiers in Pharmacology
主題:	denosumab biosimilar immunogenicity pharmacokinetics pharmacodynamics inter-subject variability
在線閱讀:	https://www.frontiersin.org/article/10.3389/fphar.2020.01329/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!